Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast (2016-2021)
Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast (2016-2021) BioPortfolio has been marketing business and market research reports from selected publishers for over fifteen years. BioPortfolio offers a personal service to our customers with dedicated research managers who will work with you to source the best report for your needs. Based in the UK, BioPortfolio is well positioned to coordinate our customers' orders sourced from over 50 global report publishers. We are pleased to present details of this report to assist your buying decision and administrative process. You will find easy-to-use How To Buy information on the last page of this document. We look forward to being of service to you. If you have bulk and/or recurring requirements, please get in touch - we can liaise with publishers to obtain sample pages and negotiate discounts on your behalf. Phone: +44 (0)1300 321501 or Email: reportstore@bioportfolio.com 2
Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast (2016-2021) An alpha-fetoprotein (AFP) test is a blood test that measures the amount of AFP present in blood. It s usually part of what s called a triple screen or quad screen in the second trimester of pregnancy. The AFP protein found in humans is encoded by the AFP gene that is located on chromosome 4. The yolk sac and immature liver of an unborn baby produce AFP which then circulates through the fetal and maternal blood. Infants usually have higher levels of AFP protein which falls to normal adult level by the end of first year. AFP tests are commercially available and widely used for testing various cancer related test. AFP market is expected to increase due to increasing awareness towards cancer and globally increasing incidences of cancer and related illnesses which is also driving cancer diagnostic segment globally and is growing exponentially with huge expenditure being done on research and development activities being carried out to discover new techniques and specific antigens to further enhance the treatment mode This report identifies the AFP Testing market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to AFP Testing market. Globally AFP Testing market is expected to witness growth in the upcoming future due to increasing cancer awareness and growing number of geriatric population which are more susceptible to cancer. North America represents highest market share in the global AFP Testing market followed by Europe and Asia-Pacific with the second and third highest market share amongst all the major regions. This market research report on global alpha-fetoprotein (AFP) Testing market is segmented based on the cancer type, as follows: Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer and Others (Cirrhosis, and Hepatitis) This is report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for alpha-fetoprotein in each of the region. This report identifies all the major companies operating in the AFP Testing market. Some of the major companies profiles in detail are as follows: Abott Laboratories Becton Dickinson Biomedical Diagnostics Bio-Rad Laboratories 3
Beckman Coulter Roche Diagnostics Additional Details Publisher : Industry ARC Reference : HCR 0109 Number of Pages : 0 Report Format : PDF Publisher Information : IndustryARC is the Leading Provider of Market Research Reports, Custom Consulting Services, Data Analytics and Industry Analysis. Our goal is to provide the right information required by the stakeholder at the right point of time, in a format which assists an intelligent and informed decision making process! We provide profound information with a proactive collaboration with the clients to identify new opportunities and guide them to find the best strategy for finding growth avenues. Our in-depth Research Reports with analysis done by experienced consultants and inputs from industry experts, Key Opinion Leaders (KOLs) span multiple sectors such as: 4
Table Of Contents for Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast (2016-2021) [Report Updated: 22-01-2016] 1. AFP Testing Market Overview2. Executive Summary 3. Market Landscape3.1. Market Share Analysis3.2. Comparative Analysis3.2.1. Product Benchmarking3.2.2. End User Profiling3.2.3. Top 5 Financials Analysis4. AFP Testing Market Forces4.1. Drivers4.1.1. Increasing awareness amongst people about cancers4.2. Restraints4.3. Opportunities4.4. Challenges4.5. Porter s Five Forces Analysis4.5.1. Bargaining Power of Suppliers4.5.2. Bargaining Power of Buyers4.5.3. Threat of New Entrants4.5.4. Threat of Substitutes4.5.5. Degree of Competition5. AFP Testing Strategic Analysis5.1. Value Chain Analysis5.2. Pricing Analysis 5.3. Opportunities Analysis5.4. Product/Market Life Cycle Analysis5.5. Suppliers and Distributors6. Global AFP Testing Market, By Cancer Type (2014-2021)6.1. Liver Cancer6.2. Testes Cancer6.3. Ovarian Cancer6.4. Biliary Tract Cancer6.5. Stomach Cancer6.6. Pancreatic Cancer6.7. Others (Cirrhosis, and Hepatitis)7. Global AFP Testing Market, By Geography (2014-2021)7.1. Europe7.1.1. Germany7.1.2. France7.1.3. Italy7.1.4. Spain7.1.5. Russia7.1.6. U.K.7.1.7. Rest of Europe7.2. Asia Pacific7.2.1. China7.2.2. India7.2.3. Japan7.2.4. South Korea7.2.5. Rest of Asia-Pacific7.3. North America 7.3.1. U.S.7.3.2. Canada7.3.3. Mexico7.4. Rest of the World (RoW)7.4.1. Brazil7.4.2. Rest of RoW8. AFP Testing Market Entropy8.1. Expansion8.2. Technological Developments8.3. Merger & Acquisitions, and Joint Ventures8.4. Supply- Contract9. Company Profiles (Top 10 Companies)9.1. Abott Laboratories9.1.1. Introduction9.1.2. Financials9.1.3. Key Insights9.1.4. Key Strategy9.1.5. Product Portfolio9.1.6. SWOT Analysis9.2. Becton Dickinson 9.2.1. Introduction9.2.2. Financials9.2.3. Key Insights9.2.4. Key Strategy9.2.5. Product Portfolio9.2.6. SWOT Analysis9.3. Biomedical Diagnostics9.3.1. Introduction9.3.2. Financials9.3.3. Key Insights9.3.4. Key Strategy9.3.5. Product Portfolio9.3.6. SWOT Analysis9.4. Bio-Rad Laboratories 9.4.1. Introduction9.4.2. Financials9.4.3. Key Insights9.4.4. Key Strategy9.4.5. Product Portfolio9.4.6. SWOT Analysis9.5. Beckman Coulter 9.5.1. Introduction9.5.2. Financials9.5.3. Key Insights9.5.4. Key Strategy9.5.5. Product Portfolio9.5.6. SWOT Analysis9.6. Roche Diagnostics 9.6.1. Introduction9.6.2. Financials9.6.3. Key Insights9.6.4. Key Strategy9.6.5. Product Portfolio9.6.6. SWOT Analysis9.7. Kreatech Diagnostics 9.7.1. Introduction9.7.2. Financials9.7.3. Key Insights9.7.4. Key Strategy9.7.5. Product Portfolio9.7.6. SWOT Analysis9.8. Mackay Life Sciences 9.8.1. Introduction9.8.2. Financials9.8.3. Key Insights9.8.4. Key Strategy9.8.5. Product Portfolio9.8.6. SWOT Analysis9.9. Siemens Healthcare 9.9.1. Introduction9.9.2. Financials9.9.3. Key Insights9.9.4. Key Strategy9.9.5. Product Portfolio9.9.6. SWOT Analysis9.10. Panacea Pharmaceuticals 9.10.1. Introduction9.10.2. Financials9.10.3. Key Insights9.10.4. Key Strategy9.10.5. Product Portfolio9.10.6. SWOT Analysis*More than 40 Companies are profiled in this Research Report, Complete List available on Request*"*Financials would be provided on a best efforts basis for private companies"10. Appendix10.1. Abbreviations10.2. Sources10.3. Research Methodology10.4. Expert Insights 5
List Of Tables in Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast (2016-2021) [Report Updated: 22-01-2016] No 6
How to Buy... Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast (2016-2021) [Report Updated: 22-01-2016] Option 1 - Online Go to our website and pay online with any major debit or credit card: Option 2 - Request a Proforma Invoice Fill in the details below, and either Scan this page and email it to us at reportstore@bioportfolio.com or Fax it to us at +44 (0)1305 791844.We will send you a Proforma Invoice and deliver your report on settlement. Your Name: Job Title: Your Email: Your Contact Phone: Company Name: Address: Post/Zip Code: Country: P.O. Number: Any Other Instructions: Pricing Options: (please tick one) $5250 Single User Price $6250 Site License Price $8450 Enterprise License Price Payment Options: (please tick one) Online Credit Card (we will email you the invoice with a payment link) Direct Wire Transfer (we will email you the invoice with our bank details) Authorising Signature: Option 3 - Phone Us on +44 (0)1300 321501 We will be delighted to give you our personal attention. 7